Profilo
Kelly Sims is currently working as a Director at Shape Therapeutics, Inc. and as a Partner at Thrive Capital Management, LLC.
Previously, Sims worked as a Vice President-San Francisco Division at The Abernathy MacGregor Group, Inc. Sims completed an undergraduate degree at the University of Iowa.
Posizioni attive di Kelly Sims
| Società | Posizione | Inizio |
|---|---|---|
Thrive Capital Management, LLC
Thrive Capital Management, LLC Investment ManagersFinance Thrive Capital seeks investment opportunities in companies located in the United States. The firm focuses on companies operating in the fields of internet, software and technology services. It provides financing for seed and early-stage capital requirements. | Investitore di Private Equity | 01/06/2022 |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Direttore/Membro del Consiglio | 26/04/2022 |
Precedenti posizioni note di Kelly Sims
| Società | Posizione | Fine |
|---|---|---|
The Abernathy MacGregor Group, Inc.
The Abernathy MacGregor Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Corporate Officer/Principal | - |
Formazione di Kelly Sims
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
The Abernathy MacGregor Group, Inc.
The Abernathy MacGregor Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Commercial Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thrive Capital Management, LLC
Thrive Capital Management, LLC Investment ManagersFinance Thrive Capital seeks investment opportunities in companies located in the United States. The firm focuses on companies operating in the fields of internet, software and technology services. It provides financing for seed and early-stage capital requirements. | Finance |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Health Technology |
















